• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G173
Device Problems Premature Discharge of Battery (1057); Pacing Problem (1439); Telemetry Discrepancy (1629)
Patient Problems No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2019
Event Type  Injury  
Event Description
It was reported that this patient was admitted to hospital with a complete atrioventricular block (av block) and a substantial decrease in the battery longevity of this device was observed.The physicians were unable to interrogate this device and alleged the device battery had prematurely depleted.The physician elected to explant and replace this device to resolve the event and the patient was stable with no additional adverse consequences.The device is expected for analysis, but has not yet been received.
 
Event Description
It was reported that this patient was admitted to hospital with a complete atrioventricular block (av block) and a substantial decrease in the battery longevity of this device was observed.The physicians were unable to interrogate this device and alleged the device battery had prematurely depleted.The physician elected to explant and replace this device to resolve the event and the patient was stable with no additional adverse effects.The device was subsequently received for analysis.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.External visual inspection of the device revealed no anomalies.Collectively, the pattern of irregular daily battery voltage measurements in conjunction with normal power levels and device hybrid current draw is consistent with behavior of devices where a latent current leakage path has occurred within the battery itself, resulting in a partial depletion of the battery.A design enhancement was implemented in 2013 to enlarge the physical barrier between the battery's anode and cathode electrode layers to prevent current leakage.This device was manufactured with this enhancement, which was expected to improve but not completely eliminate this behavior.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10653640
MDR Text Key210571637
Report Number2124215-2020-16955
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/24/2016
Device Model NumberG173
Device Catalogue NumberG173
Device Lot Number100922
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/06/2020
Initial Date Manufacturer Received 07/29/2020
Initial Date FDA Received10/08/2020
Supplement Dates Manufacturer Received07/28/2021
Supplement Dates FDA Received10/27/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age63 YR
-
-